Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Beta Aminoketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Patent CN110003110B reveals a green photocatalytic route for aryl beta-aminoketones, offering cost reduction and mild conditions for pharmaceutical manufacturing.
Patent CN114213254B details a visible-light mediated synthesis of beta-nitroketones. Offers high yield, mild conditions, and scalable routes for pharmaceutical intermediates.
Novel nickel catalyzed carbonylation method offers cost effective high purity beta aminoketone derivatives for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN121021342A reveals a mild nickel-catalyzed method for beta-aminoketone derivatives, offering cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN121021342A reveals a mild nickel-catalyzed method for beta-aminoketones using formic acid, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
This nickel-catalyzed synthesis method enables high-purity API intermediates with reduced manufacturing costs and faster commercial scale-up for pharmaceutical supply chains.